Frequently Asked Questions (FAQ)
What is Regen Institute?
Regen Institute is a doctor-led, face-to-face medical clinic focused on regenerative medicine, musculoskeletal care, injury recovery, tissue repair, and post-operative orthopaedic support. We provide structured assessment, treatment planning, and follow-up rather than one-off or transactional treatment.
What types of therapies do you offer?
We offer doctor-led regenerative medicine care, which may include peptide therapy where clinically appropriate. Our care model also includes assessment, treatment planning, pathology review where indicated, monitoring, rehabilitation guidance, and follow-up.
What is peptide therapy?
Peptide therapy refers to the medical use of specific peptides as part of a broader treatment plan where clinically appropriate. At Regen Institute, peptide therapy is considered within a structured clinical pathway and is not offered as a stand-alone quick fix.
Do you offer stem cells?
No. Regen Institute does not offer stem cell therapies.
Do you offer testosterone replacement therapy (TRT) or hormone replacement therapy?
No. Regen Institute does not provide testosterone replacement therapy or hormone replacement therapy.
Do you prescribe peptide therapy to everyone who books?
No. Attending Regen Institute does not guarantee that any medication will be prescribed, including peptide therapy. Prescribing decisions are made only after clinical assessment and only where treatment is considered appropriate and justified.
What kinds of conditions may be considered for regenerative medicine or peptide therapy?
We commonly assess persistent musculoskeletal and soft-tissue conditions, injury recovery concerns, tissue repair issues, reduced mobility, and recovery that has plateaued after surgery or first-line care. Whether treatment is appropriate depends on the diagnosis, severity, medical history, current function, and broader care plan.
Am I a suitable candidate for peptide therapy?
Suitability depends on more than symptoms alone. We consider the working diagnosis, previous treatment, pathology results, imaging where relevant, medical history, current medications, overall health, and whether there is a reasonable clinical basis for treatment. Some patients will be suitable for assessment but not for medication.
If I have had recent pathology, can I use that instead of repeating tests?
Possibly. If you have had recent pathology, we may be able to use it, particularly if it is current and clinically relevant. In some cases, additional or updated testing may still be needed before treatment can be considered. Please email us to discuss at support@regeninstitute.com.au
How recent does my pathology need to be?
There is no single rule for every patient. As a general guide, pathology from the last 6 months may sometimes be used if it is relevant and complete, but additional or repeat testing may still be required depending on the condition being assessed, the treatment being considered, and any changes in your health since the tests were done.
Do I need imaging before I attend?
Not always. Some patients already have relevant imaging, while others may not need it initially. If imaging is important for diagnosis or treatment planning, this will be discussed as part of your assessment.
Is peptide therapy lifelong or short term?
It depends on the condition, the treatment plan, and how you respond. In many cases, treatment is considered for a defined period and then reviewed. Regen Institute does not approach care as an open-ended prescribing model without reassessment.
How is Regen Institute different from online peptide clinics?
Regen Institute is a face-to-face, doctor-led clinic. We focus on careful assessment, patient selection, informed consent, medically supervised prescribing where appropriate, and ongoing review. Treatment is considered within a broader recovery plan rather than as fast, one-size-fits-all access.
How is Regen Institute different from buying peptides online or from non-medical sources?
Safe sourcing matters. Not all products described as peptides are sourced, manufactured, stored, or supplied to the same standard. At Regen Institute, any prescribed medicine is considered within a medical framework, using regulated supply pathways and clinical oversight. Official Australian guidance also states that peptides are only allowed when prescribed by a doctor for a genuine medical condition.
Do you provide treatment on the first visit?
Not necessarily. The first step is assessment. Depending on the case, we may recommend further investigation, coordination with your existing treating team, rehabilitation adjustments, monitoring, or no medication at all.
Do I need a referral?
Not always. Some patients attend directly, while others are referred by their GP, physiotherapist, osteopath, chiropractor, surgeon, or other health professional. Any information provided about the injury or presenting issue is valuable and allows for a greater overall assessment and treatment planning.
Will you communicate with my GP, physio, surgeon, or other treating clinician?
Where appropriate, yes. Regen Institute supports coordinated care and may communicate with your existing treating team to help ensure treatment is integrated and clinically appropriate.
Do you only see athletes?
No. We see adults with a range of musculoskeletal, injury, and recovery-related concerns. You do not need to be an athlete to be assessed.
Is peptide therapy evidence-based?
Peptide therapy sits within an evolving area of medicine. The level of evidence varies depending on the specific peptide, the condition being treated, and the patient group.
For many peptides used in musculoskeletal and regenerative contexts, the current evidence base is limited in human clinical trials. Much of the available data comes from preclinical research, including laboratory and animal studies, which explore potential mechanisms such as tissue repair, inflammation modulation, and cellular signalling.
While some peptides have emerging human data in selected conditions, this evidence is not yet consistent or definitive across all indications. As a result, outcomes can vary and should not be considered predictable or guaranteed.
From a regulatory perspective in Australia, many peptides used in this context are not included on the Australian Register of Therapeutic Goods (ARTG) for musculoskeletal or regenerative indications. This means they are considered unapproved (or “unregistered”) for these uses.
Where peptide therapy is prescribed, it is done under a doctor’s clinical judgement and within the relevant regulatory framework. This may include use through appropriate prescribing pathways for unapproved medicines, where clinically justified.
This regulatory status reflects the current state of evidence and places responsibility on the prescribing doctor to:
Assess whether there is a reasonable clinical basis for treatment
Determine whether the potential benefits justify the risks and uncertainties
Ensure patients are fully informed about the level of evidence, limitations, and alternatives
At Regen Institute, this means peptide therapy is only considered following careful assessment and is discussed with a clear explanation of what is known, what remains uncertain, and how it fits within a broader treatment plan.
Is regenerative medicine a replacement for physiotherapy or rehabilitation?
No. In many cases, rehabilitation remains an important part of care. Regenerative medicine and peptide therapy, where used, are considered within a broader clinical and functional recovery plan.
What happens after I enquire?
The usual process is intake, review, and then invitation to book if appropriate. Some patients may also have a discovery call before a formal consultation. Any treatment discussion happens only after proper assessment.
What if I am not suitable for peptide therapy?
If peptide therapy is not appropriate, we may recommend alternative next steps such as further investigation, revised rehabilitation, ongoing conservative care, review by another clinician, or no treatment through Regen Institute.
Does booking a consultation guarantee treatment?
No. Booking a consultation does not guarantee that treatment will be recommended or prescribed. Our role is to assess what is clinically appropriate, not to provide guaranteed access to medication.